Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
GW5015156 in Metabolic Syndrome
NCT00841217Phase 4Completed
- Sponsor
- The University of Western Australia
- Start
- Apr 2003
- Primary completion
- Aug 2005
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised trial in metabolic syndrome comparing Placebo with GW501516 (2 arms). Primary endpoint: Apolipoprotein B transport rate at 5 weeks. Started Apr 2003; status: completed.
02
Drugs
GW501516
03
Conditions
metabolic syndrome
Beyond the preview
Go deeper on NCT00841217.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00841217.